Clinical trial

Fibroscan® and Its Dedicated Probes Efficiency in Obese Patients

NCT00926224

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-07-01

PhaseNA

Study timeline

Study start (unknown)2009-07-01Date precision: month

Registry last updated2010-11-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Liver Fibrosisunresolved

Cirrhosisunresolved

Interventions

FibroScan M and XL probesDEVICE

Sponsors & collaborators

Echosenslead sponsor

Mapped research locations

TorontoOntario, Canada2 MontrealQuebec, Canada1 LondonOntario, Canada1 CalgaryAlberta, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00926224 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.